CCCCCCNC(=O)OC12CN(C(=O)OC(C)C)N(C(=O)OC(C)C)CC1(O)CN(S(=O)(=O)c1ccc(C)cc1)C2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?